Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGPhase 1INTERVENTIONAL

Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department

Feasibility and Safety of Single Dose Ketamine for Acutely Suicidal Patients in the Emergency Department

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

There is currently no readily available pharmacologic intervention for suicidal ideation, a true psychiatric emergency, in the Emergency Department (ED). Investigators aim to trial low-dose, intravenous ketamine, a drug with well-established use in treatment-resistant depression, for patients who present to the ED with suicidal ideation.

Who May Be Eligible (Plain English)

Who May Qualify: - Acutely Suicidality ("yes" answer to any of items 4 or 5 on C-SSRS "Suicidal Ideation" category) - Require inpatient stabilization for SI or actions based on clinical observation and interview - Are accepted for psychiatric stabilization at the University of Kansas Medical Center's Strawberry Hill campus - Have a Glasgow Coma Score (GCS) of 15 - Age 18-65 Who Should NOT Join This Trial: - Current or past history of psychosis - Current or recent (past 4 weeks) symptoms of mania/hypomania as defined by Young Mania Rating Scale (YRMS) score of 12 or greater - History of ketamine use disorder - History of liver transplant - Pregnancy or breastfeeding - Imprisonment or inability to consent - Positive urine drug screen or serum alcohol level - Hypertension (SBP \> 160 or DBP \> 100 before administration of ketamine) - Hypotension (SBP \< 90) - Presence of acute medical condition requiring admission to medical service - Allergy, intolerance, or previous adverse reaction to ketamine - Patient has 8+ lifetime ketamine exposures - The treating physician determines that the patient is not a good candidate for the study (e.g. medical condition/procedure, medication that would contradindicate ketamine treatment) Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Acutely Suicidality ("yes" answer to any of items 4 or 5 on C-SSRS "Suicidal Ideation" category) * Require inpatient stabilization for SI or actions based on clinical observation and interview * Are accepted for psychiatric stabilization at the University of Kansas Medical Center's Strawberry Hill campus * Have a Glasgow Coma Score (GCS) of 15 * Age 18-65 Exclusion Criteria: * Current or past history of psychosis * Current or recent (past 4 weeks) symptoms of mania/hypomania as defined by Young Mania Rating Scale (YRMS) score of 12 or greater * History of ketamine use disorder * History of liver transplant * Pregnancy or breastfeeding * Imprisonment or inability to consent * Positive urine drug screen or serum alcohol level * Hypertension (SBP \> 160 or DBP \> 100 before administration of ketamine) * Hypotension (SBP \< 90) * Presence of acute medical condition requiring admission to medical service * Allergy, intolerance, or previous adverse reaction to ketamine * Patient has 8+ lifetime ketamine exposures * The treating physician determines that the patient is not a good candidate for the study (e.g. medical condition/procedure, medication that would contradindicate ketamine treatment)

Treatments Being Tested

DRUG

Ketamine

Patients will receive 0.2mg/kg of IV ketamine

Locations (2)

University of Kansas Strawberry Hill Campus
Kansas City, Kansas, United States
University of Kansas Medical Center Emergency Department
Kansas City, Kansas, United States